Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bioregenx (BRGX) Non Operating Income (2023 - 2024)

Bioregenx's Non Operating Income history spans 2 years, with the latest figure at -$67553.0 for Q3 2024.

  • Quarterly results put Non Operating Income at -$67553.0 for Q3 2024, down 33.82% from a year ago — trailing twelve months through Sep 2024 was -$522359.0 (down 257.64% YoY), and the annual figure for FY2023 was -$461508.0, changed.
  • Non Operating Income for Q3 2024 was -$67553.0 at Bioregenx, down from -$66331.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of -$45732.0 in Q1 2023 to a low of -$315453.0 in Q4 2023.